| Dr Mark Christopher Barry, OD | |
|
1837 156th Ave Ne, Bellevue, WA 98007-4387 | |
| (425) 643-2020 | |
| (425) 643-0859 |
| Full Name | Dr Mark Christopher Barry |
|---|---|
| Gender | Male |
| Speciality | Optometrist - Corneal And Contact Management |
| Location | 1837 156th Ave Ne, Bellevue, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326041666 | NPI | - | NPPES |
| 2015857 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152WC0802X | Optometrist - Corneal And Contact Management | 1758TX (Washington) | Primary |
| Provider Name | Overlake Eyecare Ps |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1770580086 PECOS PAC ID: 4284521170 Enrollment ID: O20040304000152 |
News Archive
Endocrine disruptors are a class of chemicals used to produce materials commonly found in everyday life, such as some plastics, tin cans, electrical and household appliances, cosmetics, pesticides, etc.
IBBL will over the next three years contribute to the Interreg project Codex4SMEs. The € 3.13 million project aims to build a transnational network to accelerate the development of so-called companion diagnostics by small and medium-sized businesses and hence to promote personalized medicine in Europe.
A study published in the May/June issue of Health Affairs reports on the first randomized trial providing a scientifically valid look at what one might expect from chronic disease management programs that serve low-income individuals. The study result provides good news for state Medicaid leaders struggling to meet the needs of individuals with chronic conditions and also suggests that some disease management efforts, even among relatively low-risk patients, may be an effective strategy.
In a recently published article in The Lancet's Child & Adolescent Health, scientists have described in detail neurological and psychiatric manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children. As mentioned in the study, an estimated prevalence of infection-related neurological complications and pediatric inflammatory multisystem syndrome in hospitalized children and adolescents is about 3.8 cases per 100 patients.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported fourth-quarter and full-year 2010 financial results, provided an update on recent progress with its programs, and announced 2011 objectives.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Christopher Barry, OD 910 N 32nd St, Renton, WA 98056-2131 Ph: (425) 271-6420 | Dr Mark Christopher Barry, OD 1837 156th Ave Ne, Bellevue, WA 98007-4387 Ph: (425) 643-2020 |
News Archive
Endocrine disruptors are a class of chemicals used to produce materials commonly found in everyday life, such as some plastics, tin cans, electrical and household appliances, cosmetics, pesticides, etc.
IBBL will over the next three years contribute to the Interreg project Codex4SMEs. The € 3.13 million project aims to build a transnational network to accelerate the development of so-called companion diagnostics by small and medium-sized businesses and hence to promote personalized medicine in Europe.
A study published in the May/June issue of Health Affairs reports on the first randomized trial providing a scientifically valid look at what one might expect from chronic disease management programs that serve low-income individuals. The study result provides good news for state Medicaid leaders struggling to meet the needs of individuals with chronic conditions and also suggests that some disease management efforts, even among relatively low-risk patients, may be an effective strategy.
In a recently published article in The Lancet's Child & Adolescent Health, scientists have described in detail neurological and psychiatric manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children. As mentioned in the study, an estimated prevalence of infection-related neurological complications and pediatric inflammatory multisystem syndrome in hospitalized children and adolescents is about 3.8 cases per 100 patients.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported fourth-quarter and full-year 2010 financial results, provided an update on recent progress with its programs, and announced 2011 objectives.
› Verified 1 days ago
Aimee Liu, OD Optometrist Medicare: Medicare Enrolled Practice Location: 15600 Ne 8th St Ste F13a, Bellevue, WA 98008 Phone: 425-641-7482 Fax: 425-505-2156 | |
Britlynn Chan, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 11120 Ne 33rd Pl, Bellevue, WA 98004 Phone: 206-426-2584 | |
Adl Vision Llc Optometrist Medicare: Medicare Enrolled Practice Location: 15600 Ne 8th St Ste F13a, Bellevue, WA 98008 Phone: 425-641-7482 Fax: 425-505-2156 | |
Thomas Xie, Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1020 108th Ave Ne Apt 1401, Bellevue, WA 98004 Phone: 347-687-0712 | |
Dr. Grant Edward Lindberg, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 12310 Ne 8th St, Suite 101, Bellevue, WA 98005 Phone: 425-455-0001 Fax: 425-462-7387 | |
Joanna Stedman Haws, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 12310 Ne 8th St, Suite 101, Bellevue, WA 98005 Phone: 425-455-0001 Fax: 425-462-7387 | |
Dr. Theodore Stephen Kadet, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 14030 Ne 24th St, Suite 101, Bellevue, WA 98007 Phone: 425-462-7800 Fax: 425-455-3019 |